Cerebral venous sinus thrombosis as the first manifestation of Neuro-Behcet's disease: one case report and literature review

doi:10.3969/j.issn.1004-583X.2021.02.014

Abstract

Abstract:

Neuro-Behcet's disease (NBD) represents the involvement of the nervous system in patients with Behcet's disease (BD). The central nervous system manifestations of NBD are divided into parenchyma type and non-parenchyma type. Cerebral venous sinus thrombosis(CVST) serves as main manifestation of NBD non-parenchymal type. CVST, a rare manifestation in BD patients, is usually complicated with cranial hypertension involving the headache, vomitin, and papilledema. BD mainly relies on clinical diagnosis due to the lack of specific diagnostic test. It is necessary to consider the occurrence of BD with CVST for young male patients suffering from persistent headache and increased intracranial pressure. A young male patient with CVST as the first manifestation is introduced, and the literature related to BD combined with CVST are reviewed.

Key words: sinus thrombosis, intracranial, Behcet syndrome

CLC Number:

R743.33

Yin Yuanyuan, Ren Huiling. Cerebral venous sinus thrombosis as the first manifestation of Neuro-Behcet's disease: one case report and literature review[J]. Clinical Focus, 2021, 36(2): 162-167.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.02.014

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I2/162

Figures/Tables 5

References 29

[1]	Borhani-Haghighi A, Kardeh B, Banerjee S, et al. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment[J]. Mult Scler Relat Disord, 2019,39:101906. doi: S2211-0348(19)30977-0 pmid: 31887565
[2]	Sakane T, Takeno M, Suzuki N, et al. Behçet's disease[J]. N Engl J Med, 1999,341(17):1284-1291. doi: 10.1056/NEJM199910213411707 URL
[3]	杨庆林, 王佳伟, 赖春涛. 白塞病相关卒中[J]. 中国卒中杂志, 2017,12(5):432-435.
[4]	Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group[J]. Brain, 1999,122(Pt 11):2171-2182. doi: 10.1093/brain/122.11.2171 URL
[5]	Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management[J]. Lancet Neurology, 2009,8(2):192-204. doi: 10.1016/S1474-4422(09)70015-8 pmid: 19161910
[6]	Shi J, Huang X, Li G, et al. Cerebral venous sinus thrombosis in Behcet's disease: a retrospective case-control study[J]. Clin Rheumatol, 2018,37(1):51-57. doi: 10.1007/s10067-017-3718-2 URL
[7]	Saip S, Akman-Demir G, Siva A. Neuro-Behçet syndrome[J]. Handb Clin Neurol, 2014,121:1703-1723.
[8]	Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update[J]. Curr Neurol Neurosci Rep, 2019,19(10):74-74. doi: 10.1007/s11910-019-0988-x pmid: 31440838
[9]	Uluduz D, Midi I, Duman T, et al. Behcet's disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study[J]. Rheumatology (Oxford), 2019,58(4):600-608. doi: 10.1093/rheumatology/key153 pmid: 29992235
[10]	de Sousa DA, Mestre T, Ferro JM. Cerebral venous thrombosis in Behçet's disease: a systematic review[J]. J Neurol, 2011,258(5):719-727. doi: 10.1007/s00415-010-5885-9 URL
[11]	Akdal G, Yaman A, Men S, et al. Pseudotumor cerebri syndrome without cerebral venous sinus thrombosis in Behcet's disease[J]. J Neurol Sci, 2017,383:99-100. doi: 10.1016/j.jns.2017.10.038 URL
[12]	Greco A, De Virgilio A, Ralli M, et al. Behçet's disease: New insights into pathophysiology, clinical features and treatment options[J]. Autoimmun Rev, 2018,17(6):567-575. doi: 10.1016/j.autrev.2017.12.006 URL
[13]	The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria[J]. J Eur Acad Dermatol Venereol, 2014,28(3):338-347. doi: 10.1111/jdv.12107 URL
[14]	Kirino Y, Ideguchi H, Takeno M, et al. Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational study[J]. Arthritis Res Ther, 2016,18(1):217. doi: 10.1186/s13075-016-1115-x URL
[15]	Takeuchi M, Mizuki N, Meguro A, et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility[J]. Nat Genet, 2017,49(3):438-443. doi: 10.1038/ng.3786 URL
[16]	Mizuki Y, Horita N, Horie Y, et al. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey[J]. Mod Rheumatol, 2019, 10.1080/14397595.2019.1649103:1-7.
[17]	Chamorro AJ, Marcos M, Hernández-García I, et al. Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis[J]. Autoimmun Rev, 2013,12(5):607-616. doi: 10.1016/j.autrev.2012.11.001 URL
[18]	Krumb E, Lefebvre C, Peeters A, et al. Cerebral venous thrombosis revealing Behcet's disease in a Moroccan patient: A case report and literature review[J]. SAGE Open Med Case Rep, 2018, 6:2050313x18767053.
[19]	Brenière C, Blanc C, Devilliers H, et al. Associated arterial and venous cerebral manifestations in Behçet's disease[J]. Rev Neurol (Paris), 2018,174(5):337-341. doi: 10.1016/j.neurol.2017.06.031 URL
[20]	Yesilot N, Bahar S, Yilmazer S, et al. Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies[J]. J Neurol, 2009,256(7):1134-1142. doi: 10.1007/s00415-009-5088-4 URL
[21]	Gao Y, Lyu S, Bao L, et al. Sudden unilateral vision loss in an adult with Behcet disease: A case report[J]. Medicine (Baltimore), 2018,97(50):e13594. doi: 10.1097/MD.0000000000013594 URL
[22]	Ksiaa I, Abroug N, Kechida M, et al. Eye and Behcet's disease[J]. J Fr Ophtalmol, 2019,42(4):e133-e146. doi: 10.1016/j.jfo.2019.02.002 pmid: WOS:000464334600001
[23]	Alghamdi A, Bodaghi B, Comarmond C, et al. Neuro-ophthalmological manifestations of Behçet's disease[J]. Br J Ophthalmol, 2019,103(1):83-87. doi: 10.1136/bjophthalmol-2017-311334 pmid: 29699980
[24]	Jalli R, Zarei F, Farahangiz S, et al. The sensitivity, specificity, and accuracy of contrast-enhanced t1-weighted image, t2*-weighted image, and magnetic resonance venography in diagnosis of cerebral venous sinus thrombosis[J]. J Stroke Cerebrovasc Dis, 2016,25(8):2083-2086. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.039 pmid: 27177920
[25]	Kovacs MJ. Letter by Kovacs regarding article, “Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association”[J]. Stroke, 2011,42(7):e408.
[26]	Koennecke HC. Cerebral venous thrombosis in adults[J]. Vasa, 2019,48(6):473-482. doi: 10.1024/0301-1526/a000788 URL
[27]	Roriz M, Crassard I, Lechtman S, et al. Can anticoagulation therapy in cerebral venous thrombosis associated with Behcet's disease be stopped without relapse?[J]. Rev Neurol (Paris), 2018,174(3):162-166. doi: 10.1016/j.neurol.2017.06.021 URL
[28]	Terashita S, Tanaka T, Taneichi H, et al. Mycophenolate mofetil and prednisolone for cerebral sinus venous thrombosis with Behcet's disease[J]. Pediatr Int, 2019,61(9):920-922. doi: 10.1111/ped.13943 pmid: 31512337
[29]	Duman T, Uluduz D, Midi I, et al. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study[J]. J Stroke Cerebrovasc Dis, 2017,26(8):1848-1857. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.020 URL